Aims: Coronary artery bypass grafts (CABGs) are increasingly performed in elderly patients. Risk factors and outcomes are poorly described for those undergoing noncardiac surgery within 1 year after ...
MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) failure among patients who undergo coronary artery bypass surgery, the ...
A surge of cardiac troponins appeared to be the norm even after uneventful coronary artery bypass graft (CABG) surgery, a prospective study confirmed, and how high these biomarkers go depended on the ...
We identified 211 patients who had a noncardiac surgical procedure within 1 year after CABG. We report patient characteristics and medical history in Table 1. Variables and outcomes associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results